Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis.

NCT00350415 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00350415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00350415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis.
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
May 31, 2007
Enrollment
772 (actual)
Sites
135

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis